Ongoing D&O Disclosures – Multiple

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Rua Bioscience Limited (Rua)
Date this disclosure made:
10/11/2021
Date of last disclosure:
2/11/2021
Director or senior manager giving disclosure
Full name(s):
Panapa Ehau
Name of listed issuer:
Rua
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Director of Rua
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Options to acquire ordinary shares in
Rua under Rua's share option plan
Nature of the affected relevant interest(s):
Entitlement to become legal and
beneficial owner of ordinary shares in
Rua subject to the meeting of certain
vesting conditions and other terms
and conditions under Rua's share
option plan
For that relevant interest-
Number held in class before acquisition or disposal:
Nil
Number held in class after acquisition or disposal:
59,800 options to acquire 59,800
ordinary shares in Rua
Current registered holder(s):
New options issue
Registered holder(s) once transfers are registered:
Panapa Ehau
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Details of transactions giving rise to acquisition or disposal
DocuSign Envelope ID: BCF32289-4B19-44C7-96DF-0DA9085AE186

Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:18/10/2021
Nature of transaction:
Acquisition of 59,800 options to
acquire 59,800 ordinary shares in
Rua
Name of any other party or parties to the transaction (if known):
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Services provided by Panapa Ehau
to Rua
Number of financial products to which the transaction related:
59,800 options to acquire 59,800
ordinary shares in Rua
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Ordinary shares in Rua
Nature of relevant interest:Registered and beneficial owner
For that relevant interest,-
Number held in class:473,498
Current registered holder(s):Panapa Ehau
For a derivative relevant interest,-
Type of derivative:N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Ordinary shares in Rua
Nature of relevant interest:
Director and shareholder of Waiapu
Investments Limited (WIL). WIL is
the registered holder and beneficial
owner of 726 shares in Rua
For that relevant interest,-
Number held in class:726
Current registered holder(s):Waiapu Investments Limited
For a derivative relevant interest,-
Type of derivative:N/A
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:N/A
Maturity date of the derivative (if any):N/A
Expiry date of the derivative (if any):N/A
The price's specified terms (if any):N/A
DocuSign Envelope ID: BCF32289-4B19-44C7-96DF-0DA9085AE186

Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative relevant interest,- N/A
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:10/11/2021
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
DocuSign Envelope ID: BCF32289-4B19-44C7-96DF-0DA9085AE186

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Rua Bioscience Limited
Date this disclosure made:
10-Nov-21
Date on which issuer listed or appointment made:
30-Jun-21
Director or senior manager giving disclosure
Full name:
Andrea Grant
Name of listed issuer:
Rua Bioscience Limited
Name of related body corporate (if applicable):
Position held in listed issuer:
Chief Commercial Office
r
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product:
Ordinary shares in Rua Bioscience
Limited
Number held in class: 2,373.6144
Nature of relevant interest: Beneficial owner
Current registered holder: Sharesies Nominee Limited
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying
products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:N/A
Maturity date of the derivative (if any):N/A
Expiry date of the derivative (if any):N/A
The price specified in the terms of the derivative(if any):N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
Parties to the derivative:N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:10-Nov-21
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Rua Bioscience Limited (Rua)
Date this disclosure made:
10/11/2021
Date of last disclosure:
10/11/2021
Director or senior manager giving disclosure
Full name(s):
Andrea Grant
Name of listed issuer:
Rua
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chief Commercial Officer of Rua
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Options to acquire ordinary shares in
Rua under Rua's share option plan
Nature of the affected relevant interest(s):
Entitlement to become legal and
beneficial owner of ordinary shares in
Rua subject to the meeting of certain
vesting conditions and other terms
and conditions under Rua's share
option plan
For that relevant interest-
Number held in class before acquisition or disposal:
Nil
Number held in class after acquisition or disposal:
285,000 options to acquire 285,000
ordinary shares in Rua
Current registered holder(s):
New options issue
Registered holder(s) once transfers are registered:
Andrea Grant
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A

Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:18/10/2021
Nature of transaction:
Acquisition of 285,000 options to
acquire 285,000 ordinary shares in
Rua
Name of any other party or parties to the transaction (if known):
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Services provided by Andrea Grant
to Rua
Number of financial products to which the transaction related:
285,000 options to acquire 285,000
ordinary shares in Rua
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Ordinary shares in Rua
Nature of relevant interest:Beneficial owner
For that relevant interest,-
Number held in class:2,373.6144
Current registered holder(s):Sharsies Nominee Limited
For a derivative relevant interest,-
Type of derivative:N/A
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:N/A
Maturity date of the derivative (if any):N/A
Expiry date of the derivative (if any):N/A
The price's specified terms (if any):N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative relevant interest,- N/A
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:10/11/2021

or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person: